Market overview
The global dual lumen ECMO catheter market is worth USD 73 mn in 2026 and is forecast to reach USD 166 mn by 2036, growing at a 8.5% CAGR. United States is the largest country market and Bicaval jugular catheters is the largest by design segment.
| Scope | Single-cannula dual-lumen catheters used to drain and return blood through one vein in veno-venous ECMO: bicaval and pulmonary-artery designs in adult and paediatric sizes. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 68 mn |
| Value 2026 | USD 73 mn |
| Value 2036 | USD 166 mn |
| CAGR 2026-2036 | 8.5% |
| Volume 2026 | 27.0 thousand units |
| Volume 2036 | 61.0 thousand units |
| Average price 2026 | USD 2,720 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Dual Lumen ECMO Catheter market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 73 mn |
| 2027 | USD 80 mn |
| 2028 | USD 86 mn |
| 2029 | USD 94 mn |
| 2030 | USD 102 mn |
| 2031 | USD 110 mn |
| 2032 | USD 120 mn |
| 2033 | USD 130 mn |
| 2034 | USD 141 mn |
| 2035 | USD 153 mn |
| 2036 | USD 166 mn |
Dual Lumen ECMO Catheter market segmentation
By design
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Bicaval jugular catheters | 56.0% | 51.2% | USD 41 mn | 7.5% |
| Pulmonary artery to right atrium catheters | 30.0% | 36.0% | USD 22 mn | 10.5% |
| Paediatric and neonatal catheters | 14.0% | 12.8% | USD 10 mn | 7.5% |
By care setting
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Adult intensive care units | 54.0% | 54.1% | USD 40 mn | 8.5% |
| Cardiac and ECMO centres | 28.0% | 29.4% | USD 21 mn | 9.0% |
| Paediatric and neonatal intensive care | 18.0% | 16.5% | USD 13 mn | 7.5% |
By catheter size
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Small bore up to 20 Fr | 24.0% | 26.0% | USD 18 mn | 9.4% |
| Medium 21 to 27 Fr | 46.0% | 45.0% | USD 34 mn | 8.3% |
| Large 28 Fr and above | 30.0% | 29.0% | USD 22 mn | 8.1% |
By coating
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Heparin-coated | 48.0% | 52.0% | USD 35 mn | 9.4% |
| Uncoated | 34.0% | 28.0% | USD 25 mn | 6.4% |
| Other antithrombogenic coatings | 18.0% | 20.0% | USD 13 mn | 9.7% |
By indication
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Acute respiratory distress syndrome | 40.0% | 36.0% | USD 29 mn | 7.4% |
| Viral and bacterial pneumonia | 12.0% | 10.0% | USD 8.8 mn | 6.5% |
| Cardiogenic shock support | 20.0% | 22.0% | USD 15 mn | 9.5% |
| Bridge to transplant | 18.0% | 20.0% | USD 13 mn | 9.7% |
| Other respiratory failure | 10.0% | 12.0% | USD 7.3 mn | 10.5% |
Top 25 countries for dual lumen ECMO catheter by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 84.0% of 2026 revenue and the 25 countries below together hold 95.5%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 29 mn | 40.0% | USD 67 mn | 8.6% |
| 2 | China | USD 7.3 mn | 10.0% | USD 20 mn | 10.6% |
| 3 | Germany | USD 6.6 mn | 9.0% | USD 14 mn | 7.6% |
| 4 | France | USD 3.7 mn | 5.0% | USD 7.6 mn | 7.6% |
| 5 | Japan | USD 3.7 mn | 5.0% | USD 7.3 mn | 7.1% |
| 6 | United Kingdom | USD 2.9 mn | 4.0% | USD 6.5 mn | 8.2% |
| 7 | Italy | USD 2.2 mn | 3.0% | USD 4.3 mn | 7.0% |
| 8 | Spain | USD 2.2 mn | 3.0% | USD 4.7 mn | 7.8% |
| 9 | Australia | USD 2.2 mn | 3.0% | USD 5.0 mn | 8.5% |
| 10 | Netherlands | USD 1.5 mn | 2.0% | USD 3.1 mn | 8.0% |
| 11 | Canada | USD 1.1 mn | 1.4% | USD 2.2 mn | 7.6% |
| 12 | South Korea | USD 0.94 mn | 1.3% | USD 2.5 mn | 10.1% |
| 13 | Brazil | USD 0.70 mn | 1.0% | USD 1.5 mn | 7.7% |
| 14 | India | USD 0.70 mn | 1.0% | USD 2.2 mn | 12.1% |
| 15 | Switzerland | USD 0.59 mn | 0.8% | USD 1.2 mn | 7.7% |
| 16 | Belgium | USD 0.59 mn | 0.8% | USD 1.2 mn | 7.7% |
| 17 | Turkey | USD 0.59 mn | 0.8% | USD 1.5 mn | 10.2% |
| 18 | Sweden | USD 0.47 mn | 0.6% | USD 0.98 mn | 7.6% |
| 19 | Saudi Arabia | USD 0.47 mn | 0.6% | USD 1.2 mn | 10.1% |
| 20 | Taiwan | USD 0.47 mn | 0.6% | USD 0.98 mn | 7.6% |
| 21 | Mexico | USD 0.47 mn | 0.6% | USD 0.98 mn | 7.6% |
| 22 | Austria | USD 0.35 mn | 0.5% | USD 0.73 mn | 7.6% |
| 23 | Poland | USD 0.35 mn | 0.5% | USD 0.73 mn | 7.6% |
| 24 | Israel | USD 0.35 mn | 0.5% | USD 0.73 mn | 7.6% |
| 25 | Denmark | USD 0.35 mn | 0.5% | USD 0.73 mn | 7.6% |
| Rest of world | USD 3.3 mn | 4.5% | USD 7.3 mn | 8.3% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Getinge
- Medtronic
- LivaNova
Group 2: Regional and specialist players
- Terumo
- Xenios
- Eurosets
Group 3: Emerging and niche players
- Origen Biomedical
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the dual lumen ECMO catheter market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 8.5% is calculated from the resulting values.
The market is divided by design, by care setting, by catheter size, by coating, by indication. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the dual lumen ECMO catheter market?
The global dual lumen ECMO catheter market is estimated at USD 68 mn in 2025 and USD 73 mn in 2026.
How fast will the dual lumen ECMO catheter market grow?
It is forecast to reach USD 166 mn by 2036, a compound annual growth rate of 8.5% from 2026, an increase of USD 93 mn.
Which country is the largest market for dual lumen ECMO catheter?
United States is the largest market by revenue at USD 29 mn in 2026, 40.0% of the global total. The three largest countries together hold 59.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 10.6% a year from 2026 to 2036.
Which dual lumen ECMO catheter segment is largest?
In the by design split, Bicaval jugular catheters is the largest segment with 56.0% of 2026 revenue.
Who are the leading dual lumen ECMO catheter companies?
Global leaders include Getinge, Medtronic, LivaNova.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Emergency Transfer Vacuum MattressUSD 74 mn · 5.0% CAGR
- Ophthalmic Gas DeliveryUSD 74 mn · 4.8% CAGR
- AI Osteoporosis Screening ToolsUSD 74 mn · 18.0% CAGR
- Touch Activated Phlebotomy DevicesUSD 72 mn · 18.0% CAGR
- Federated Learning HealthcareUSD 78 mn · 22.0% CAGR
- Vaccine CryoprotectantsUSD 81 mn · 8.0% CAGR
- AI Capsule Endoscopy Reading PlatformUSD 64 mn · 17.0% CAGR
- Respiration Monitor BeltUSD 63 mn · 5.2% CAGR